The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma.
Times cited: 105
Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma.
Times cited: 32
Development of a real-time polymerase chain reaction assay for prediction of the uptake of meta-[(131)I]iodobenzylguanidine by neuroblastoma tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research.
Times cited: 33